title: Cytotoxicity and altered c-myc gene expression by medical polyacrylamide hydrogel.
abstract: Medical Polyacrylamide Hydrogel (PAMG)has been used in plastic and aesthetic surgery for years. However, its safety is still in doubt in many countries. In the current research, first an approach, using high performance liquid chromatography (HPLC), to determine the amount of residual acrylamide monomer (AM) in the PAMG was presented. Then the cytotoxicity of PAMG was investigated using cell counting and methyl thiazolyl tetrazolium (MTT) assay. To explore the mechanism of this toxicity, normal human fibroblasts cultured in medium extracts were analyzed. Membrane changes and other related parameters were investigated using flow cytometry (FCM). Real time fluorescent polymerase chain reaction (real time PCR) was also introduced to determine the biological response of the fibroblasts. During this process, three representative genes (p53, beta-actin, and c-myc, which are tumor suppressor genes, housekeeping genes, and proto-oncogenes respectively) were selected for examination. Results indicated that a method based on HPLC is practical and simple for determining AM in PAMG. The detection limits can reach the desired ppb level, and so it can fully meet the requirements of the studies of PAMG. Polyacylamide Hydrogel inhibits the growth of human fibroblasts and may cause the apoptosis of human fibroblasts. Moreover, it can alter physical parameters such as the size and the granularity of these cells. Furthermore, these three genes have a relatively typical amplification plot and highly related, wide-range standard curves, and so this reaction system is definitely suitable for the semiquantification of these genes. PAMG induces the increase of the message ribonucleic acid (mRNA) expression of c-myc, while the p53 and beta-actin remain even. This change is not related to the concentration of AM in the gel and may be incited by other components in the extract of PMAG.
authors.affiliation: Center for Medical Devices, National Institute for the Control of Pharmaceutical and Biological Products, Beijing 100050, People's Republic of China. xitingfei@tom.com
authors.forename: T F
authors.initials: TF
authors.lastname: Xi
authors.forename: C X
authors.initials: CX
authors.lastname: Fan
authors.forename: X M
authors.initials: XM
authors.lastname: Feng
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Wan
authors.forename: C R
authors.initials: CR
authors.lastname: Wang
authors.forename: L L
authors.initials: LL
authors.lastname: Chou
mesh_terms: D000180:Acrylic Resins / Q000032:analysis*; D017304:Annexin A5 / Q000378:metabolism; D002470:Cell Survival; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D005347:Fibroblasts / Q000166:cytology* / Q000502:physiology; D005434:Flow Cytometry; D005782:Gels; D005786:Gene Expression Regulation; D016259:Genes, myc; D006801:Humans; D016133:Polymerase Chain Reaction / Q000379:methods; D012313:RNA / Q000235:genetics / Q000302:isolation & purification
chemical_list: D000180:Acrylic Resins; D017304:Annexin A5; D005782:Gels; C016680:polyacrylamide gels; D012313:RNA